在近日举行的《中国企业家》"2025影响力企业家年会"上，高途创始人、董事长兼CEO陈向东发表题 为"韧性生长"的主题演讲，系统阐述了其对企业穿越周期、实现可持续增长的核心思考。 这场演讲不仅呼应了高途近期在财报电话会上宣布的战略方向——将"盈利"作为2026财年核心目标，更 揭示了这家教育科技企业从高速增长迈向高质量发展的深层逻辑。 从"看见"到"相信"：变局中的战略定力 陈向东表示，韧性不仅是逆境中坚持前行的能力，更是在顺境中持续保持复原力与内在喜悦的智慧。回 顾高途自身的发展轨迹，他坦言，正是这些起伏促使团队不断追问："我们这一辈子究竟想要什么？" 在演讲中，陈向东对一句广为流传的创业格言 "因为相信，所以看见"提出了反思，转而强调一个更朴 素却更真实的逻辑："因为看见，所以相信。"真正的战略定力，不是源于盲目的信念，而是建立在对趋 势、技术和市场变化的清晰"看见"之上。这种"看得更远、更准"的能力，正是企业家最核心的洞察力。 回望高途的创立，正是这种"看见"促成了行动。2014年，移动互联网浪潮初起，音视频技术趋于成熟， 陈向东凭借早年电子技术专业背景与十余年教育行业经验，敏锐捕捉到技术与教育融合的巨 ...

Group 1 - The core idea emphasizes that effective management is crucial for business success, and it introduces the concept of "Four Views" for better business operations [1][22] Group 2 - "Horizontal View": Benchmarking against industry peers is essential to avoid insular thinking and to identify gaps in performance [3][5][7] - "Vertical View": Long-term thinking is necessary to prevent short-sightedness, as businesses must consider the future value of their actions [9][11][13] Group 3 - "Backward View": Starting with the end goal in mind helps in defining clear paths and milestones, ensuring that resources are allocated effectively [14][15][17] Group 4 - "Perspective Shift": Understanding the needs of employees, customers, and partners through empathy can enhance engagement and operational efficiency [18][19][20][21]

Group 1 - The core viewpoint of the article highlights the contrasting dynamics in the innovative drug market, where while there is a resurgence in public market interest, the primary market remains challenging for fundraising [1][4][22] - In 2025, over 60 innovative drug companies saw their stock prices double, driven by numerous business development (BD) transactions, yet the primary market for innovative drugs is still experiencing a downturn, with a 7.4% decrease in financing events and a 24.5% drop in total financing amount compared to the previous year [3][4] - A survey indicated that 60% of biotech leaders believe the primary market has emerged from its lowest point, but 33% feel it remains stagnant, reflecting ongoing difficulties in fundraising [4][13] Group 2 - Founders of innovative drug companies report significant challenges in securing funding, with one entrepreneur stating that it often requires discussions with over 100 institutions to secure investment [2][14] - The investment landscape has shifted, with investors now focusing more on the commercialization capabilities of companies rather than just scientific concepts, indicating a more cautious approach to funding [15][16] - The current investment environment is characterized by a preference for later-stage assets, with investors seeking clear milestones and clinical data to support funding decisions [15][17] Group 3 - The exit environment remains pressured, with 74% of biotech respondents indicating that the lack of exit channels is a major factor affecting investment enthusiasm [23][24] - Despite some improvements in the IPO landscape, many companies still face difficulties in finding buyers for their shares, leading to a stagnation in the cash flow cycle of equity investments [25][26] - The pressure for exits is compounded by the reluctance of state-owned capital to take on high-risk, non-profitable assets, further complicating the fundraising landscape [26][31] Group 4 - There is a concern that the current wave of BD transactions may lead to a gap in investment opportunities in the future, as the influx of capital has not kept pace with the needs of emerging technologies [33][34] - Data shows a stark contrast in financing amounts between domestic and international markets, particularly in gene therapy, indicating a potential lag in innovation if funding does not improve [34] - Investors express cautious optimism about the future, suggesting that a stable policy environment and successful public market performance could stimulate renewed interest in the primary market [34][35]

Group 1 - The article emphasizes the importance of self-love and self-awareness as essential assets for personal happiness and fulfillment [1] - It discusses the journey of self-discovery and the need to recognize and appreciate oneself, even amidst challenges [1] - The author reflects on the pressures of societal expectations and the importance of self-acceptance [1] Group 2 - The article outlines seven habits that contribute to personal effectiveness and growth, emphasizing a sequential approach [2] - The first three habits focus on self-management and personal victories, while the next three emphasize collaboration and public victories [2] - The final habit encourages continuous self-renewal and improvement across various aspects of life [2] Group 3 - Habit one, "Be Proactive," distinguishes between passive and proactive mindsets, highlighting the importance of personal choice in responses to external stimuli [10][4] - Habit two, "Begin with the End in Mind," stresses the necessity of having clear goals to avoid distractions and misdirection [13] - Habit three, "Put First Things First," emphasizes prioritizing important tasks over urgent ones to achieve long-term benefits [29][31] Group 4 - Habit four, "Think Win-Win," introduces the concept of emotional bank accounts in relationships, advocating for mutual benefit in interactions [40] - Habit five, "Seek First to Understand, Then to Be Understood," focuses on empathetic listening and understanding others' perspectives [45] - Habit six, "Synergize," encourages leveraging differences to create greater outcomes than individual efforts [60] Group 5 - Habit seven, "Sharpen the Saw," emphasizes the importance of self-renewal in physical, mental, emotional, and social aspects to maintain effectiveness [63] - The article concludes by reiterating the significance of these habits in achieving a fulfilling and balanced life [66][74]